Verge Genomics

Verge Genomics, based in San Francisco, CA, is at the forefront of biotechnology, utilizing advanced all-in-human artificial intelligence to revolutionize drug discovery. By leveraging a proprietary multi-omics database derived from human tissue, the company aims to address significant medical challenges and accelerate the development of effective treatments.

With a focus on diseases such as amyotrophic lateral sclerosis, Parkinson's Disease, and Frontotemporal Dementia, Verge's innovative platform has already led to the clinical development of its first drug candidate in just four years. The team, comprised of drug hunters, engineers, and neuroscientists, is committed to transforming the landscape of drug discovery through collaboration and a pioneering culture in the biotech industry.

Generated from the website